BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 31331555)

  • 1. Not all cancer patients with an interest in CAM are the same. Differences between patients with a CAM interest prior to the cancer diagnosis and those with first-time interest since diagnosis.
    Dubois C; Eisfeld H; Bauer F; Schmidt T; Kastrati K; Hochhaus A; Hübner J
    Complement Ther Med; 2019 Aug; 45():167-171. PubMed ID: 31331555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Information needs and usage of complementary and alternative medicine in members of a German self-help group for gastrointestinal stroma tumours, sarcoma, and renal cancer.
    Bauer F; Schmidt T; Eisfeld H; Dubois C; Kastrati K; Hochhaus A; Huebner J
    Complement Ther Med; 2018 Dec; 41():105-110. PubMed ID: 30477825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of complementary and integrative medicine among German breast cancer patients: predictors and implications for patient care within the PRAEGNANT study network.
    Fremd C; Hack CC; Schneeweiss A; Rauch G; Wallwiener D; Brucker SY; Taran FA; Hartkopf A; Overkamp F; Tesch H; Fehm T; Hadji P; Janni W; Lüftner D; Lux MP; Müller V; Ettl J; Belleville E; Sohn C; Schuetz F; Beckmann MM; Fasching PA; Wallwiener M
    Arch Gynecol Obstet; 2017 May; 295(5):1239-1245. PubMed ID: 28331996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of complementary and alternative medicine among breast cancer patients in Hungary: A descriptive study.
    Sárváry A; Sárváry A
    Complement Ther Clin Pract; 2019 May; 35():195-200. PubMed ID: 31003658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence, patterns, and perceived value of complementary and alternative medicine among cancer patients: a cross-sectional, descriptive study.
    Bahall M
    BMC Complement Altern Med; 2017 Jun; 17(1):345. PubMed ID: 28666435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of complementary and alternative medicine among Korean cancer patients.
    Kim MJ; Lee SD; Kim DR; Kong YH; Sohn WS; Ki SS; Kim J; Kim YC; Han CJ; Lee JO; Nam HS; Park YH; Kim CH; Yi KH; Lee YY; Jeong SH
    Korean J Intern Med; 2004 Dec; 19(4):250-6. PubMed ID: 15683114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of complementary and alternative medicine by patients in routine care and the risk of interactions.
    Firkins R; Eisfeld H; Keinki C; Buentzel J; Hochhaus A; Schmidt T; Huebner J
    J Cancer Res Clin Oncol; 2018 Mar; 144(3):551-557. PubMed ID: 29356888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complementary and Alternative Medicine Use in Cancer Patients in Rural Australia.
    Sullivan A; Gilbar P; Curtain C
    Integr Cancer Ther; 2015 Jul; 14(4):350-8. PubMed ID: 25873293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attitudes about the use of complementary and alternative medicine in cancer treatment.
    Schernhammer ES; Haidinger G; Waldhör T; Vutuc C
    J Altern Complement Med; 2009 Oct; 15(10):1115-20. PubMed ID: 19848548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examining the association between patient-centered communication and provider avoidance, CAM use, and CAM-use disclosure.
    Faith J; Thorburn S; Tippens KM
    Altern Ther Health Med; 2015; 21(2):30-5. PubMed ID: 25830278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in patients with inflammatory bowel disease: results from a German national survey.
    Langhorst J; Anthonisen IB; Steder-Neukamm U; Lüdtke R; Spahn G; Michalsen A; Dobos GJ
    Inflamm Bowel Dis; 2005 Mar; 11(3):287-95. PubMed ID: 15735435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology.
    Richardson MA; Sanders T; Palmer JL; Greisinger A; Singletary SE
    J Clin Oncol; 2000 Jul; 18(13):2505-14. PubMed ID: 10893280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Status of Using Complementary and Alternative Medicine among Patients with Cancer in Korea: an Online Survey of Online Cancer Support Groups (KCSG PC21-20).
    Kim JS; Kwon JH; Rha SY; Lee SC; Chang YJ; Kwon IS; You KH; Yoon HY
    Cancer Res Treat; 2023 Apr; 55(2):442-451. PubMed ID: 36596728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complementary and alternative medicine use among patients with cancer in Mongolia: a National hospital survey.
    Oyunchimeg B; Hwang JH; Ahmed M; Choi S; Han D
    BMC Complement Altern Med; 2017 Jan; 17(1):58. PubMed ID: 28103860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer patients' use of complementary and alternative medicine in Sweden: a cross-sectional study.
    Wode K; Henriksson R; Sharp L; Stoltenberg A; Hök Nordberg J
    BMC Complement Altern Med; 2019 Mar; 19(1):62. PubMed ID: 30866916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementary and Alternative Medicine Use and Its Association with Emotional Status and Quality of Life in Patients with a Solid Tumor: A Cross-Sectional Study.
    Jang A; Kang DH; Kim DU
    J Altern Complement Med; 2017 May; 23(5):362-369. PubMed ID: 28453297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex differences in motives for use of complementary and alternative medicine among cancer patients.
    Hedderson MM; Patterson RE; Neuhouser ML; Schwartz SM; Bowen DJ; Standish LJ; Marshall LM
    Altern Ther Health Med; 2004; 10(5):58-64. PubMed ID: 15478787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of complementary and alternative medicine by cancer patients is not associated with perceived distress or poor compliance with standard treatment but with active coping behavior: a survey.
    Söllner W; Maislinger S; DeVries A; Steixner E; Rumpold G; Lukas P
    Cancer; 2000 Aug; 89(4):873-80. PubMed ID: 10951352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complementary and alternative medicine use among cancer patients in Palestine with special reference to safety-related concerns.
    Ali-Shtayeh MS; Jamous RM; Salameh NM; Jamous RM; Hamadeh AM
    J Ethnopharmacol; 2016 Jul; 187():104-22. PubMed ID: 27125594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer patients' perspectives on and use of complementary and alternative medicine: a study by the Susan G. Komen Breast Cancer Foundation.
    Astin JA; Reilly C; Perkins C; Child WL;
    J Soc Integr Oncol; 2006; 4(4):157-69. PubMed ID: 17022924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.